These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 29783391)

  • 1. Genetic variation and antipsychotic drug effects on serum lipids.
    Hallman DM
    Per Med; 2008 Jan; 5(1):77-81. PubMed ID: 29783391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allelic variation in ApoC3, ApoA5 and LPL genes and first and second generation antipsychotic effects on serum lipids in patients with schizophrenia.
    Smith RC; Segman RH; Golcer-Dubner T; Pavlov V; Lerer B
    Pharmacogenomics J; 2008 Jun; 8(3):228-36. PubMed ID: 17726453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study.
    Hallman DM; Srinivasan SR; Chen W; Boerwinkle E; Berenson GS
    Metabolism; 2006 Dec; 55(12):1574-81. PubMed ID: 17142127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of apolipoprotein A5 (APOA5) polymorphisms on serum triglyceride levels in schizophrenic patients under long-term atypical antipsychotic treatment.
    Hong CJ; Chen TT; Bai YM; Liou YJ; Tsai SJ
    World J Biol Psychiatry; 2012 Jan; 13(1):22-9. PubMed ID: 21375366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy.
    Arnedo M; Taffé P; Sahli R; Furrer H; Hirschel B; Elzi L; Weber R; Vernazza P; Bernasconi E; Darioli R; Bergmann S; Beckmann JS; Telenti A; Tarr PE;
    Pharmacogenet Genomics; 2007 Sep; 17(9):755-64. PubMed ID: 17700364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of genetic risk for dyslipidemia.
    Yamada Y; Matsuo H; Warita S; Watanabe S; Kato K; Oguri M; Yokoi K; Metoki N; Yoshida H; Satoh K; Ichihara S; Aoyagi Y; Yasunaga A; Park H; Tanaka M; Nozawa Y
    Genomics; 2007 Nov; 90(5):551-8. PubMed ID: 17919884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of APOA5 and APOC3 gene polymorphisms with plasma apolipoprotein A5 level in patients with metabolic syndrome.
    Niculescu LS; Vlădică M; Sima AV
    Biochem Biophys Res Commun; 2010 Jan; 391(1):587-91. PubMed ID: 19932084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of olanzapine and risperidone on lipid metabolism in chronic schizophrenic patients with long-term antipsychotic treatment: a randomized five month study.
    Smith RC; Lindenmayer JP; Hu Q; Kelly E; Viviano TF; Cornwell J; Vaidhyanathaswamy S; Marcovina S; Davis JM
    Schizophr Res; 2010 Jul; 120(1-3):204-9. PubMed ID: 20457512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein A5 and apolipoprotein C3 single nucleotide polymorphisms are correlated with an increased risk of coronary heart disease: a case-control and meta-analysis study.
    Yang G; Lei MM; Yu CL; Liu XX; An Z; Song CL
    Lipids Health Dis; 2015 Sep; 14():113. PubMed ID: 26387083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma apolipoprotein A5 and triglycerides in type 2 diabetes.
    Dallinga-Thie GM; van Tol A; Hattori H; van Vark-van der Zee LC; Jansen H; Sijbrands EJ;
    Diabetologia; 2006 Jul; 49(7):1505-11. PubMed ID: 16752169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strong association of the APOA5-1131T>C gene variant and early-onset acute myocardial infarction.
    De Caterina R; Talmud PJ; Merlini PA; Foco L; Pastorino R; Altshuler D; Mauri F; Peyvandi F; Lina D; Kathiresan S; Bernardinelli L; Ardissino D;
    Atherosclerosis; 2011 Feb; 214(2):397-403. PubMed ID: 21130994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of apolipoprotein C3 genetic polymorphisms on serum lipid levels and the risk of intracerebral hemorrhage.
    Jiang Y; Ma J; Li H; Liu Y; You C
    Lipids Health Dis; 2015 May; 14():48. PubMed ID: 25994187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant association of APOA5 and APOC3 gene polymorphisms with meat quality traits in Kele pigs.
    Hui YT; Yang YQ; Liu RY; Zhang YY; Xiang CJ; Liu ZZ; Ding YH; Zhang YL; Wang BR
    Genet Mol Res; 2013 Sep; 12(3):3643-50. PubMed ID: 24085428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research.
    Arranz MJ; de Leon J
    Mol Psychiatry; 2007 Aug; 12(8):707-47. PubMed ID: 17549063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of APOA5 -1131T>C polymorphism and serum lipid levels in patients with type 2 diabetes.
    Celap I; Simundic AM; Nikolac N; Kackov S; Katalinic D
    DNA Cell Biol; 2013 Oct; 32(10):589-93. PubMed ID: 23919616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Searching susceptibility genes for antipsychotic-induced weight gain: is the 5-HT2C receptor gene a promising candidate?
    Hong KS; Park T
    Per Med; 2007 Aug; 4(3):357-361. PubMed ID: 29788662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effects of genetic variants of APOA5 and BTN2A1 on dyslipidemia or metabolic syndrome.
    Hiramatsu M; Oguri M; Kato K; Horibe H; Fujimaki T; Watanabe S; Satoh K; Aoyagi Y; Tanaka M; Shin DJ; Lee JH; Jang Y; Yamada Y
    Int J Mol Med; 2012 Jul; 30(1):185-92. PubMed ID: 22576629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of APOA5/A4/C3 genetic polymorphisms on lipid variables and cardiovascular disease risk in French men.
    Dallongeville J; Cottel D; Montaye M; Codron V; Amouyel P; Helbecque N
    Int J Cardiol; 2006 Jan; 106(2):152-6. PubMed ID: 16321685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of clozapine on levels of total cholesterol and related lipids in serum of patients with schizophrenia: a prospective study.
    Dursun SM; Szemis A; Andrews H; Reveley MA
    J Psychiatry Neurosci; 1999 Nov; 24(5):453-5. PubMed ID: 10586536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.